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Full-thickness chest wall resection for locally recurrent
breast cancer
Die allschichtige Thoraxwandresektion bei Lokalrezidiven des
Mammakarzinoms
Abstract
Aim: In spite of available recommendations, therapeutic procedures of
locally recurrent breast cancer are very different. In a retrospective
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Zusammenfassung
Vorhaben: Die Therapie des Lokalrezidives des Mammakarzinoms wird
trotz vorliegender Empfehlungen sehr uneinheitlich durchgeführt. Mit
der retrospektiven Untersuchung sollen die Möglichkeiten und Ergeb-
nisse der kompletten, allschichtigen Brustwandresektion aufgezeigt
werden.
Methode:Zwischen1985und2004wurdebei51Fraueneinekomplet-
te, allschichtige Thoraxwandresektion mit primärer Deckung durchge-
führt. Die primäre, operative Therapie des Mammakarzinoms bestand
bei 88% in einer Mastektomie. Das Alter betrug bei der Operation des
Lokalrezidives im Median 57 (29 - 81) Jahre. Das mediane Intervall
zwischenPrimärtumoroperationundLokalrezidivoperationbetrug70,3
(10,7 - 327,2) Monate, die mediane Follow-up Zeit betrug 29,4 (1,8 -
230,9) Monate. Rippen wurden bei 40 (78,4%) Patienten reseziert, bei
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Patientinnen wurde eine komplette und bei 7 (13,7%) eine partielle
Sternumresektion ohne zusätzliche Rippenresektion durchgeführt. Die
DeckungwurdehauptsächlichmittelsmuskulokutanerLatissimusdorsi
Lappen durchgeführt (86,3%, n=44). Die Überlebensdaten wurden mit
der Kaplan-Meier Methode, das relative Risiko mit der univariaten und
multivariaten Cox-Regression berechnet.
Ergebnisse: Die kumulative 5, 10 und 15-Jahresüberlebenszeit (Jü)
beträgt für die gesamte Gruppe 39%, 31% und 23%, das mediane
Überleben 46,4 Monate. Bei R0 Resektion beträgt die 5-Jü 42%. Pro-
gnostische Faktoren waren das Alter der Patientinnen bei der Primär-
operation, das krankheitsfreie Intervall und die Tumorinfiltration von
knöchernen Strukturen. Die Letalität betrug 2%, die Morbidität 35%.
Schlussfolgerung: Die allschichtige Brustwandresektion des Lokalrezi-
dives des Mammakarzinoms ist im Team von Thorax- und plastischen
Chirurgen nahezu immer möglich. Nur durch die radikale Resektion
lassen sich gute Langzeiterfolge bei geringer Letalität und Morbidität
erzielen.
Introduction
The locoregional recurrence of breast cancer is defined
as the recurrence of a tumour in a previously operated
orirradiatedareaoftreatedbreastcancer.Theincidence
of local recurrences after mastectomy and breast-con-
serving therapy varies between 5% and 40% depending
onriskfactorsandprimarytherapy[1].Sofar,astandard
therapy of local recurrences has not been defined. It is
recommended to excise the visible tumour with sub-
sequent radiation therapy. In many cases, however, irra-
diation or chemotherapy is performed primarily. Surgical
therapy of local recurrences or chest wall metastases of
breast cancer is either not performed at all or with an in-
sufficient safety margin. Local recurrence is often misin-
terpreted as the first indication of a systemic dissemina-
tion of the disease and curative approach is therefore
abandoned [2]. Still today large ulcerated chest wall tu-
moursareseen.Whetherradicalresectionoflocalrecur-
rence offers palliative or curative approach or major pro-
longation of survival is still unclear. Moreover, chest wall
resection is often regarded as a mutilating intervention
with high morbidity and mortality. The possibility of chest
wallresectionwithplasticcoverageforcompleteresection
of chest wall recurrences is almost unknown. Given a
palliative approach, full-thickness chest wall resection
provides a markedly improved quality of life and given a
curative approach, a good chance for long-term survival.
There are, however, very few reports on results of full-
thicknesscompletechestwallresectionsforlocallyrecur-
rent breast cancer with sufficient safety margins.
Patients and methods
Between 1985 and 2004, 51 women underwent com-
plete,full-thicknesschestresectionwithprimarycoverage.
The term "local recurrence" was defined as a relapse of
tumourmanifestationsafterbreast-conservingprocedure
inmammaryregion(primarysurgicalregion),afterradical
therapy in chest wall region, covering skin, scar tissue
andremainingglandulartissue.Regionalrecurrencealso
includes the involvement of ipsilateral lymph nodes. We
included only patients with local recurrences who met
this definition.
Patient data were obtained retrospectively from the
medical records. The present condition of the patients
was documented either by regular outpatient follow-up
orbyobtaininginformationfromthefamilyphysician,the
patient herself or from relatives. Descriptive data on
primary tumour treatment are listed in Table 1. 45
(88.2%)patientshadprimarybreastresection,6(11.8%)
breast conserving surgery. Tumour stages 1 and 2 were
present in 76.5% of the patients, while it was unknown
in5(9.8%)patients.Theprimaryhormone-receptorstatus
wasunknownin43.1%(n=22).17(33.3%)patientswere
known to have an adjuvant therapy.
Resection was performed according to following stand-
ards: The visible tumour was resected with safety margin
of at least 2 cm, if possible 5 cm. If tumour invasion of a
rib was suspected, cranial and caudal ribs were resected
as well. In case of doubt of extension of tumour, frozen
sections of the margins were performed.
Atthetimeofsurgicalinterventionofthelocalrecurrence,
median age was 57 (range 29-81) years. Disease free
interval (DFI) was 70.3 months (M) (range 10.7-327.2
M).Medianfollow-upwas29.4months(range1.8-230.9
M), median follow-up of survivors 36.7 M (range 1.8-
230.9 M). Except of 5 patients, in whom replacement of
chestwallsofttissuewasnotnecessary,allinterventions
wereperformedbyateamofonethoracicandoneplastic
surgeon. Surgical data are detailed in Table 2. A mean
of 3.2 (range 1-5) ribs were resected in 40 (78.4%) pa-
tients,in15(29.4%)ofthemincombinationwithasternal
resection.In4(7.8%)patientscompletesternalresection
andin7(13.7%)patientspartialsternalresectionwithout
additional rib resection were performed. Median size of
resected material was 100 (range 36-360) cm². Chest
wall stability was restored mainly by non-absorbable
polypropylene mesh (n=23, 45.1%) or by absorbable
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polygalactin mesh (n=14, 27.5%), rarely (n=12, 23.5%)
by Gore-tex. In two cases (3.9%), no patch was used.
Coverage was mainly realized using a latisssimus dorsi
myocutaneous flap (n=44, 86.3%), in one case (2%) by
a rectus abdominis myocutaneous flap, and in two cases
(3.9%)apectoralismajormyocutaneousflap.Noaddition-
al flap coverage was necessary in four cases (7.8%).
Survival was calculated using the Kaplan-Meier method,
the impact on survival was determined for the different
factors univariate by means of the log-rank test. Calcula-
tion was started at the time of chest wall resection and
included postoperative fatalities. Relative risk and mul-
tivariate analyses were calculated by Cox Regression
analysis. Proportional hazards as well as possible colin-
earities and interdependencies were considered.
Thefollowingfactorswereincluded:boneinfiltration(yes-
no); disease free interval (≤2 years - >2 years); metas-
tases (yes - no); multilocular chest wall recurrence (yes -
no); tumor diameter (≤3 cm - >3 cm); age at primary re-
section (≤45 years - >45 years).
Statistical analyses were computed using SAS (Vers. 8;
SAS Institute, Cary, USA); Kaplan-Meier analyses and
plots were performed using SPSS (Vers. 12; Chicago,
USA).
Results
All patients were in good general condition (WHO grade
IV). In all cases, the local recurrence was completely re-
sected. Because of R1 resection one patient had to un-
dergoasecondsternalresectionafter10days.Palliative
R2 resection because of pleural carcinosis or dissemina-
tion of pulmonary metastases was performed in 6 pa-
tients. The diameter of resected tumour was 1-11 cm,
median 3 cm, in case of multilocular tumour the largest
diameter was considered.
Hospitalmortalitywas2%,i.e.onepatientdiedpostoper-
ativelyfrompulmonarycomplications.Complicationswere
observedin33%(n=17).Bleedingsneedingrevisionwere
found in 14% (n=7), flap necroses in 3.9% (n=2), and
wound infections in 7.8% (n=4), myocardial and respirat-
ory insufficiency, recurrent nerve palsy and empyema in
one patient respectively.
At the time of follow-up, 24 patients (47.1%) were still
alive, 21 (87.5%) of them without any recurrence. Cumu-
lative 5-year survival (5-YS) for the total collective was
41.1%, 10-year survival (10-YS) 28.5%, and 15-year sur-
vival 21.3%, median survival (MS) was 50.1 months.
Comparing patients with R0 resection to those with R2
resections, according to the above mentioned definition,
5- and 10-YS of completely resected patients (n=45)
amount to 41.4 and 36.8%, respectively, with a MS of
46.7 months in contrast to a 5- and 10-YS in patients
with R2 resections (n=6) of 41.7 and 0% with a MS of
57.2 months (p=0.33).
The following subgroup analyses of apparently prognos-
tically relevant parameters included only R0 resected
patients.
If the recurrence did not invade bony structures (n=28),
5- and 10-YS were 52.6% with a MS of 154.6 months. If
there was a histologically proven bone invasion (n=17),
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5-YS was 19.8% and 10-YS 9.9% with a MS of 29.4
months (p=0.03) (Figure 1).
If additional metastases of lung, pericardium or dia-
phragm were resected (n=9), 5- and 10-YS were 19.4%
with a median MS of 37.3 months. The group without
metastases (n=36) had a 5- and 10-YS of 47.3% and
41.4%, respectively, with a MS of 56.6 months (p=0.30).
If tumour size increases above 3 cm, survival apparently
tends to deteriorate. A tumour size below 3 cm (n=23)
was associated with a 5-YS of 49.3%, above 3 cm (n=22)
with only 34.2% with a MS of 46.7 and 37.3 months, re-
spectively (p=0.43).
With an DFI equal or more than 24 months (n=38), 5-
and 10-YS are 47.8% and 41.8% with a MS of 56.6
months compared to a 14.3% 5- and 10-YS with a MS of
27.7monthsifDFIwaslessthan24months(n=7)(Figure
2) (p=0.04).
Another important factor is patient age at the time of
primary surgery. Patients below 45 years of age at the
time of primary therapy of breast cancer (n=18) had a
better prognosis with a 5-YS of 70.5% and a 10-YS of
58.8%, with the median survival not being achieved so
far.Incontrast,womenabove45yearsofageatthetime
of primary therapy (n=27) had a 5- and 10-YS of 23.4%,
with a MS of 29.4 months (p=0.005) (Figure 3).
Comparingthep-valuesofsurvivalprobabilitiescalculated
by Cox-Regression, there are demonstrative results for
the expected prognostic factors bone invasion and dis-
ease-freeintervalwithp-values<0.05.Additionalmetas-
tases, multilocular manifestation of the recurrence and
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Figure 2: Cumulative survival of complete resected (R0) patients according to disease free interval
largesttumourdiameterdonothaveimpactonprognosis.
Descriptive data are given in Table 3.
Risk ratio of univariate Cox analysis shows that patients
withboneinvasionhada2.5foldhigherriskofpremature
death, patients with a disease-free interval of ≤ 2 years
had a 3-fold increased risk and patients with additional
metastases still a 1.6-fold increased risk. Patients above
45 years of age at the time of primary therapy had a 3.9-
fold increased of risk of death. For tumour diameter and
multilocular recurrence the best estimator of risk ratio is
1.5 and 2.3 respectively. Since the relevant confidence
intervalsareverybroad,thesedataonlyindicateatrend,
which however might become significant given a higher
number of cases (Table 4).
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Table 3: Characteristics of prognostic factors
Table 4: Univariate statistics of prognostic factors (patients with complete resection)
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The factors DFI, bone invasion and age at the time of
primary therapy were analysed using multivariate Cox
analysis, additionally. Only bone invasion and age at the
time of primary therapy showed demonstrative p values
below 0.05 and a risk of premature death which is 2.8
and 6.1 fold higher for patients with bone invasion and
age > 45 years at the time of primary treatment respec-
tively. The best estimator for the risk ratio of DFI was 2.6
(Table 5).
Discussion
A review of the literature showed that a complete chest
wall resection is only performed in very rare cases. The
largestcollectivereportedoninthelast20yearsincludes
69 patients [3]. Inour opinion,there aremajor therapeu-
ticshortcomingsinthisfield.Unfortunately,manypatients
are only referred for complete chest wall resection after
multipleprevioustherapeuticprocedures,notfewpatients
came on their own initiative. In our group, 27 patients
received a mean of 2.1 therapeutic procedures before
final resection. One patient each had undergone 5 and
6 surgical interventions previously. 24 patients (47%)
were primarily presented at our institution.
Guidelines on therapy of locally recurrent breast cancer
do not provide a clear therapeutic strategy. Surgical re-
sectionisrecommended,ifpossible,otherwiseradiother-
apy. Astonishingly, there is no information on safety
margins defining R0 resection [4]. In most cases, only
local excision of tumour with surrounding smooth tissue
is performed which then often proves of be R1 or R2 re-
section. As a consequence of these incomplete resec-
tions,radiotherapyisappliedinmostcases.Capgarfound
radiotherapy to be of great importance in a study of 130
very inhomogenously treated patients with local recur-
rence. However, only 25% of the patients had a complete
resection of the tumour1 [5]. Complete chest wall resec-
tionisusuallyperformedfirstafterexhaustingallalterna-
tive therapies [6]. In addition, many physicians consider
thelocalrecurrenceasaharbingerofprogressivesystem-
icmetastaticdiseaseleadingtonihilisticattitudetowards
further treatments. Although several reports have shown
that the incidence of metastases after local recurrences
is higher, the opinion that the local recurrence is a
markerofmetastaticformationmixtheprincipleofcause
andeffectup[7].Fortindemonstratedthattheincidence
of metastases increases both after manifestation of a
local recurrence and after therapy of a primary tumour
after the same time. In both cases, there is a peak after
about 2 years with a subsequent decrease in the inci-
dence of new metastases [8]. Thus, the local recurrence
has to be regarded as a repeated episode of a disease
with an increased risk of subsequent metastases and
not vice versa. The curve of metastatic incidence might
beflattenedmarkedlybyaradicalresectionwithsufficient
safety margins.
One of the most important factors is the complete resec-
tion of the tumour with sufficient safety margins of 2-5
cm. This is in most cases only possible by performing a
complete chest wall resection, which almost always is
possibleifthoracicandplasticsurgeonsarecooperating.
Fortinfoundthatresectionwithinsufficientsafetymargin
always bears a high risk of local recurrence. Adjuvant ra-
diotherapy did not reduce the risk (8). Treating local re-
currence by resecting soft tissue solely shows a re-recur-
rence rate of 45% [9] to 62% (10). Radiotherapy exclu-
sively has a re-recurrence rate of 83% [10].
Mortalityafterchestwallresectionisreportedtobe1.6%-
4.5% [11]. Hospital mortality in our collective was 2%. A
similar rate of 1.6% is reported by Henderson in a group
of61patients[11].Morbidityisreportedtobe20%-50%.
Faneyte described a complication rate of 40% in his col-
lective with surgical revision being necessary in 22% [6].
A complication rate of 41% was reported by Kluiber in a
group of 12 patients [12]. Our morbidity of 35% is within
these ranges.
Inourseriesfollowingfactorsshowedinfluenceinpredict-
ing differences of long term survival: Age at primary
treatment,tumourinvasionofbonystructures,additional
metastases and disease free interval.
As reported by Fortin, risk factors affecting long-term
survival were diameter of the local recurrence > 1.5 cm,
disease-free interval < 2 years, skin invasion and initial
tumour stage T2 or positive lymph nodes [8]. Faneyte
found age at the time of primary resection and the dis-
ease-free interval to be prognostic factors. 5-YS in the
whole collective was 45%, after R0 resection without ad-
ditional metastases 58%, in the palliative setting still
21%. Patients who were less than 35 years old at the
time of primary therapy had significantly lower survival
rates after resection of chest wall recurrence. However,
this group consists of 4 patients only, and the 5-YS is not
provided [6]. Miyauchi reported on a 5-YS of 48% in 23
patients. Prognostic factors were disease-free interval
and positive mediastinal lymph nodes [13]. Henderson
reported on a 5-YS of only 24%. However, the incidence
of incomplete resections in this group was 26%. The only
prognostic factor was additional metastases [11]. The
Sloan Kettering Cancer Centre reported on lymph node
involvementtobeariskfactor.Inhisgroupof38patients,
Downey reported on a 5-YS of 18%. If the patients with
additional metastases are excluded, 5-YS was 35%.
However, this group has an astonishingly high incidence
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of R1 and R2 resections. Downey concludes that chest
wall resection primarily represents a palliative approach
[2]. Our data do not support these results. Patients with
metastases, who underwent complete resection, had a
5-YS of 19.4%. We do not consider additional resection
of metastases per se to be a palliative intervention. In
earlier reports we have shown that metastatic resection
indeed offers a curative approach in the treatment of
breast cancer [14], [15], [16], [17]. Furthermore, it is re-
commended to always exclude metastases in view of the
factthatpatientswithadditionalmetastasesdonotprofit
from an extended chest wall resection. In order to obtain
an adequate oncological concept a complete staging is
required before starting any therapy to assess the status
of the tumour disease. On the basis of these results, the
adequatetherapeuticapproachisthenselected.Inmost
cases, however, metastatic disease does not represent
a contraindication for chest wall resection.
Even in cases of multilocular metastases, resection of
thelocalrecurrencewithapalliativepurposemaycontrib-
utetoamarkedlyimprovedqualityoflife.Palliativeresec-
tions are mostly applied in primarily irradiated patients
with a re-recurrence. Some of the tumours are ulcerated
or the patients suffer from severe pain. Even in the palli-
ative setting 5-YS rates of 21%-41.7% are reported [2],
[6].
The most ostentatious prognostic factor in our group,
however, was the age of women at the time of primary
surgery. In contrast to the common prognosis, younger
patients achieved a better prognosis by surgical therapy
of the local recurrence than older patients. Whether this
isreallyduetothetherapeuticprocedureortothegener-
ally decreased life expectancy of older patients has to be
subject of a more detailed investigation.
The results and the procedures of the references cited
are detailed in Table 6, [18], [19], [20].
Conclusion
In locally recurrent breast cancer complete chest wall
resectionmostlyisnecessarytoachieveradicalresection
with sufficient tumour free safety margins of 2-5 cm. To
enable surgical therapy and to cover large chest wall de-
fects cooperation between thoracic and plastic surgeon
is of eminent importance.
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